Infinity Pharmaceuticals Company Profile (NASDAQ:INFI)

About Infinity Pharmaceuticals

Infinity Pharmaceuticals logoInfinity Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. The Company develops small molecule drugs that target disease pathways for potential applications in oncology. Its product candidate is duvelisib, also known as IPI-145, is an oral, dual-inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K), for the treatment of hematologic malignancies, or blood cancers. The Company is also developing IPI-549, which is an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the gamma isoform of PI3K. In addition to duvelisib, the Company focuses to generate new product candidates for potential investigation in oncology. The Company also focuses on developing DYNAMO, CONTEMPO, BRAVURA, FRESCO, DYNAMO+R, DUO, SYNCHRONY and Duvelisib + Venetoclax.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: INFI
  • CUSIP: 45665G30
Key Metrics:
  • Previous Close: $1.74
  • 50 Day Moving Average: $1.56
  • 200 Day Moving Average: $4.18
  • Trailing P/E Ratio: 5.40
  • Foreward P/E Ratio: -0.90
  • P/E Growth: -0.01
  • Market Cap: $83.31M
  • Outstanding Shares: 49,587,000
  • Beta: 1.78
Additional Links:
Companies Related to Infinity Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Infinity Pharmaceuticals (NASDAQ:INFI) (?)
Ratings Breakdown: 9 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $5.00 (214.47% upside)

Analysts' Ratings History for Infinity Pharmaceuticals (NASDAQ:INFI)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016Morgan StanleyReiterated RatingHold$1.00View Rating Details
8/10/2016FBR & CoReiterated RatingHoldView Rating Details
8/9/2016WedbushReiterated RatingNeutral$1.25 -> $1.00View Rating Details
6/15/2016Jefferies GroupDowngradeBuy -> HoldView Rating Details
6/15/2016William BlairDowngradeOutperform -> Market Perform$20.00 -> $2.00View Rating Details
6/15/2016Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
6/14/2016Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$12.00 -> $2.00View Rating Details
6/14/2016JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details
6/14/2016JPMorgan Chase & Co.DowngradeOverweight -> NeutralView Rating Details
5/16/2015Stifel NicolausReiterated RatingHoldView Rating Details
5/10/2015NomuraReiterated RatingNeutral -> Buy$17.00 -> $13.00View Rating Details
5/6/2015Deutsche Bank AGInitiated CoverageBuy$20.00View Rating Details
12/4/2014Credit Suisse Group AGUpgradeNeutral -> Outperform$20.00 -> $22.00View Rating Details
9/3/2014Roth CapitalReiterated RatingPositiveView Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for Infinity Pharmaceuticals (NASDAQ:INFI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/9/2016Q216($0.89)$1.05$13.91 million$9.47 millionViewListenView Earnings Details
5/4/2016Q116($0.82)($0.82)$8.80 million$9.26 millionViewListenView Earnings Details
2/23/2016Q415($0.72)($0.80)$18.26 million$9.10 millionViewListenView Earnings Details
11/5/2015Q315($0.63)$0.84$24.85 million$90.70 millionViewN/AView Earnings Details
8/6/2015Q215($1.00)($0.78)$5.83 million$4.90 millionViewN/AView Earnings Details
5/6/2015Q115($1.68)($1.91)$5.79 million$4.40 millionViewListenView Earnings Details
2/24/2015Q414($0.98)($0.83)$5.61 million$4.36 millionViewListenView Earnings Details
11/6/2014Q314$0.30$2.03$141.40 million$160.60 millionViewListenView Earnings Details
8/5/2014Q114($0.84)($0.78)ViewN/AView Earnings Details
5/6/2014Q1($0.83)($0.87)ViewListenView Earnings Details
2/25/2014Q413($0.87)($0.68)ViewListenView Earnings Details
11/7/2013($0.75)($0.71)ViewN/AView Earnings Details
8/8/2013Q2 2013($0.62)($0.68)ViewListenView Earnings Details
11/6/2012Q312($0.57)$0.52$13.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Infinity Pharmaceuticals (NASDAQ:INFI)
Current Year EPS Consensus Estimate: $-1.87 EPS
Next Year EPS Consensus Estimate: $-1.76 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.91)($0.79)($0.85)
Q2 20164($1.02)($0.83)($0.92)
Q3 20164($0.93)($0.76)($0.88)
Q4 20164($1.04)($0.70)($0.90)
Q1 20171($0.13)($0.13)($0.13)
Q2 20171($0.12)($0.12)($0.12)
Q3 20171($0.13)($0.13)($0.13)
Q4 20171($0.13)($0.13)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Infinity Pharmaceuticals (NASDAQ:INFI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Infinity Pharmaceuticals (NASDAQ:INFI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/25/2015Adelene Q PerkinsCEOSell5,000$10.93$54,650.00View SEC Filing  
6/15/2015Vito J PalombellaInsiderSell4,737$10.97$51,964.89View SEC Filing  
5/27/2015Adelene Q PerkinsCEOSell10,000$12.81$128,100.00View SEC Filing  
5/14/2015Adelene Q PerkinsCEOSell10,000$12.18$121,800.00View SEC Filing  
3/16/2015Adelene Q PerkinsCEOSell20,000$16.00$320,000.00View SEC Filing  
1/29/2015Adelene Q PerkinsCEOSell20,000$14.83$296,600.00View SEC Filing  
12/15/2014Vito J PalombellaInsiderSell4,737$16.32$77,307.84View SEC Filing  
11/26/2014Vito J PalombellaInsiderSell4,736$15.00$71,040.00View SEC Filing  
9/30/2014Anthony B EvninDirectorSell112,451$13.56$1,524,835.56View SEC Filing  
9/3/2014Vito J PalombellaInsiderSell9,472$15.39$145,774.08View SEC Filing  
11/27/2013Anthony B EvninDirectorSell163,864$14.82$2,428,464.48View SEC Filing  
9/13/2013Adelene PerkinsCEOSell45,000$20.72$932,400.00View SEC Filing  
6/20/2013Vito J PalombellaInsiderSell23,150$18.53$428,969.50View SEC Filing  
11/26/2012Christopher M LindblomInsiderSell13,885$25.73$357,261.05View SEC Filing  
9/7/2012Co BeaconMajor ShareholderBuy5,416,565$14.50$78,540,192.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Infinity Pharmaceuticals (NASDAQ:INFI)
DateHeadline
publicnow.com logoCall announcement Infinis plc 1st quarter results for the year ending 31 March 2017 £350m 7% Senior Notes due 2019 (NASDAQ:INFI)
www.publicnow.com - August 24 at 8:44 AM
finance.yahoo.com logoINFINITY PHARMACEUTICALS, INC. Financials (NASDAQ:INFI)
finance.yahoo.com - August 19 at 5:38 PM
4-traders.com logoInfinity Pharmaceuticals : Provides Company Update And Reports Second Quarter 2016 Financial Results (NASDAQ:INFI)
www.4-traders.com - August 18 at 5:40 PM
investornewswire.com logoWill Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Surprise Analysts? - Investor Newswire (NASDAQ:INFI)
www.investornewswire.com - August 17 at 8:41 AM
News IconWorldwide Chondrosarcoma Treatment Market: Shifting Industry dynamics 2016 – 2022 (NASDAQ:INFI)
www.medgadget.com - August 16 at 5:47 PM
streetupdates.com logoMost Recent Analysts Ratings Report: Infinity Pharmaceuticals, Inc ... - Street Updates (NASDAQ:INFI)
www.streetupdates.com - August 10 at 8:31 AM
finance.yahoo.com logoEdited Transcript of INFI earnings conference call or presentation 9-Aug-16 8:30pm GMT (NASDAQ:INFI)
finance.yahoo.com - August 10 at 8:31 AM
cnbc.com logoInfinity beats 2Q profit forecasts (NASDAQ:INFI)
www.cnbc.com - August 9 at 5:47 PM
twst.com logoInfinity Pharmaceuticals Inc.: Infinity Provides Company Update And Reports Second Quarter 2016 Financial Results (NASDAQ:INFI)
www.twst.com - August 9 at 5:47 PM
publicnow.com logoInfinity Provides Company Update And Reports Second Quarter 2016 Financial Results (NASDAQ:INFI)
www.publicnow.com - August 9 at 5:47 PM
biz.yahoo.com logoINFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement (NASDAQ:INFI)
biz.yahoo.com - August 9 at 5:47 PM
biz.yahoo.com logoInfinity Pharmaceuticals Inc Earnings Call (Q2 2016) (NASDAQ:INFI)
biz.yahoo.com - August 9 at 8:37 AM
News Icon3 Troubled Pharma Stocks That Could Rally Soon Volatile pharma stocks face critical earnings tests to prove they belong in the markets (NASDAQ:INFI)
www.minyanville.com - August 9 at 8:37 AM
biz.yahoo.com logoQ2 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:INFI)
biz.yahoo.com - August 9 at 8:37 AM
equities.com logoInfinity Pharmaceuticals Inc. (INFI) Jumps 5.42% on August 03 - Equities.com (NASDAQ:INFI)
www.equities.com - August 6 at 8:32 AM
fortune.com logoAnalyst Views To Note: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) - Review Fortune (NASDAQ:INFI)
reviewfortune.com - August 3 at 8:52 AM
News IconWhat Analyst's Think about Infinity Pharmaceuticals Inc. (NASDAQ:INFI) - The Voice Registrar (NASDAQ:INFI)
voiceregistrar.com - August 3 at 8:52 AM
twst.com logoInfinity Pharmaceuticals Inc.: Infinity Announces The Date Of Its Second Quarter 2016 Financial Results Conference Call And Webcast (NASDAQ:INFI)
www.twst.com - August 2 at 5:53 PM
publicnow.com logoInfinity Announces The Date Of Its Second Quarter 2016 Financial Results Conference Call And Webcast (NASDAQ:INFI)
www.publicnow.com - August 2 at 10:28 AM
prnewswire.com logoResearch Report Coverage on Select Biotech Stocks -- Vertex Pharma, Infinity Pharma, Aduro BioTech, and Aralez Pharma (NASDAQ:INFI)
www.prnewswire.com - August 1 at 10:23 AM
biz.yahoo.com logoAbbVie Inc Earnings Call (Q2 2016) (NASDAQ:INFI)
biz.yahoo.com - July 29 at 8:34 AM
biz.yahoo.com logoINFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:INFI)
biz.yahoo.com - July 26 at 5:19 PM
marketwired.com logoPieris Pharmaceuticals Appoints Julian Adams, Ph.D., to Its Board of Directors (NASDAQ:INFI)
www.marketwired.com - July 26 at 8:36 AM
News IconBiotech news that matter for investors: Infinity Pharmaceuticals ... - The Voice Registrar (NASDAQ:INFI)
voiceregistrar.com - July 23 at 9:39 AM
ftsenews.co.uk logoInfinity Pharmaceuticals, Inc. (NASDAQ:INFI) Updated Price Targets - FTSE News (NASDAQ:INFI)
www.ftsenews.co.uk - July 22 at 8:36 AM
equities.com logoInfinity Pharmaceuticals Inc. (INFI) Jumps 8.05% on July 20 - Equities.com (NASDAQ:INFI)
www.equities.com - July 20 at 10:00 PM
streetupdates.com logoAnalyst's Noticeable Buzzers: DexCom, Inc. (NASDAQ:DXCM) , Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Street Updates (NASDAQ:INFI)
www.streetupdates.com - July 20 at 3:39 PM
News IconTrading the Biotech News: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - The Voice Registrar (NASDAQ:INFI)
voiceregistrar.com - July 20 at 3:39 PM
News IconInfinity Pharmaceuticals, Inc. (NASDAQ:INFI): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:INFI)
www.engelwooddaily.com - July 20 at 8:38 AM
News IconHeightened Volatility Spotted on Shares of: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Engelwood Daily (NASDAQ:INFI)
www.engelwooddaily.com - July 19 at 5:44 PM
News IconBiotech Stocks To Put On Your Watch List: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), EPIRUS Biopharmaceuticals ... - The Voice Registrar (NASDAQ:INFI)
voiceregistrar.com - July 19 at 5:44 PM
News IconTrading Performance and Target Watch for Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Press Telegraph (NASDAQ:INFI)
presstelegraph.com - July 18 at 5:49 PM
News IconAre Analysts Bearish Infinity Pharmaceuticals Inc. (NASDAQ:INFI) After Last Week? - Consumer Eagle (NASDAQ:INFI)
www.consumereagle.com - July 18 at 5:49 PM
News IconStocks in Queue: Oracle Corporation (NYSE:ORCL), Infinity Pharmaceuticals Inc.(NASDAQ:INFI) - NYSE Journal (press release) (NASDAQ:INFI)
stockznews.com - July 18 at 5:49 PM
news.cmlviz.com logoInfinity Pharmaceuticals Inc Stock Momentum Hits Weakness - CML News (NASDAQ:INFI)
news.cmlviz.com - July 18 at 5:49 PM
capitalcube.com logoETF’s with exposure to Infinity Pharmaceuticals, Inc. : July 18, 2016 (NASDAQ:INFI)
www.capitalcube.com - July 18 at 1:54 PM
News IconIncreased Volatility Noted on Shares of: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Engelwood Daily (NASDAQ:INFI)
www.engelwooddaily.com - July 15 at 4:42 PM
streetupdates.com logoAnalysts Rating updates about two Stocks: Valeant Pharmaceuticals International, Inc. (NYSE:VRX) , Infinity ... - Street Updates (NASDAQ:INFI)
www.streetupdates.com - July 14 at 9:09 AM
finance.yahoo.com logoDecibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer (NASDAQ:INFI)
finance.yahoo.com - July 13 at 6:01 PM
News IconBiotech veteran Holtzman joins Decibel as CEO (NASDAQ:INFI)
www.bostonglobe.com - July 13 at 6:01 PM
news.cmlviz.com logoInfinity Pharmaceuticals Inc versus XOMA Corporation Head to Head Compare - CML News (NASDAQ:INFI)
news.cmlviz.com - July 12 at 5:54 PM
News IconNow what? How biotechs deal with failure (NASDAQ:INFI)
www.bostonglobe.com - July 12 at 10:00 AM
kcregister.com logoStock Runners: Evoke Pharma, Inc. (NASDAQ:EVOK), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Cimarex Energy ... - KC Register (NASDAQ:INFI)
www.kcregister.com - July 11 at 5:43 PM
News IconStock Volatility Focus for: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) - Engelwood Daily (NASDAQ:INFI)
www.engelwooddaily.com - July 11 at 5:43 PM
News IconCompany Shares of Infinity Pharmaceuticals (NASDAQ:INFI) Rally 2.19% - TheFounders Daily (NASDAQ:INFI)
www.thefoundersdaily.com - July 11 at 5:43 PM
investornewswire.com logoWill Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Surprise This Quarter? - Investor Newswire (NASDAQ:INFI)
www.investornewswire.com - July 10 at 10:00 AM
equities.com logoInfinity Pharmaceuticals Inc. (INFI) Jumps 6.06% on July 08 - Equities.com (NASDAQ:INFI)
www.equities.com - July 10 at 10:00 AM
streetupdates.com logoAnalyst's Overview of Two Stocks: Teva Pharmaceutical Industries Limited (NYSE:TEVA) , Infinity Pharmaceuticals, Inc ... - Street Updates (NASDAQ:INFI)
www.streetupdates.com - July 7 at 5:44 PM
news.cmlviz.com logoInfinity Pharmaceuticals, Inc. versus Osiris Therapeutics, Inc. Head to Head Compare - CML News (NASDAQ:INFI)
news.cmlviz.com - July 7 at 5:44 PM
equities.com logoInfinity Pharmaceuticals Inc. (INFI) Drops 5.84% on July 05 - Equities.com (NASDAQ:INFI)
www.equities.com - July 7 at 8:31 AM

Social

Infinity Pharmaceuticals (NASDAQ:INFI) Chart for Wednesday, August, 24, 2016


Last Updated on 8/24/2016 by MarketBeat.com Staff